期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CLINICAL AND EXPERIMENTAL MEDICINE LetPub Score 6.2
50 ratings
Rate
Reputation 7.5 Influence 4.9 Speed 6.9 | ||||||||||||||||
期刊簡稱 | CLIN EXP MED | ||||||||||||||||
ISSN | 1591-8890 | ||||||||||||||||
E-ISSN | 1591-9528 | ||||||||||||||||
h-index | 39 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 3.10%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.springer.com/10238 | ||||||||||||||||
在線稿件提交 | https://submission.nature.com/new-submission/10238/3 | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Springer International Publishing | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | ITALY | ||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||
創刊年 | 2001 | ||||||||||||||||
每年文章數 | 246每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 27.58% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1591-8890%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2.5 Month(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: About 77.5% | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[CLINICAL AND EXPERIMENTAL MEDICINE] 的評論 | 撰寫評論 |
作者: 东海博学 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-25 15:39:46 評論於 Review speed: 1.0 | Submission hit rate: 75.0 Emphasized research direction: cell therapy; tumor immunity Experience sharing: Resubmitted on July 15, 2024, received review comments on July 30, 2024, minor revisions, 3 questions. Revised on August 8. Accepted on August 18. Proof on August 22.(0) 讚! | 东海博学 |
作者: 407928215 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-01 11:31:46 評論於 How much does it cost?(0) 讚! | 407928215 |
作者: 月河莉霞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-10 17:05:24 評論於 Research focus: Oncology experience sharing: It doesn't feel as fast as I imagined. I have seen articles being accepted in just one month recently. It has been almost a month since I submitted, and it still says "Your submission has passed technical checks." The publication fee is quite expensive.(0) 讚! | 月河莉霞 |
作者: 北风窅恒 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-09 14:01:37 評論於 All OA has been started, but the layout fee is still very expensive.(0) 讚! | 北风窅恒 |
作者: 文章666 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-13 16:04:34 評論於 Is it currently only available to choose open, for a fee?(0) 讚! | 文章666 |
作者: Ron Truman 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-25 13:36:42 評論於 How are you doing now?(0) 讚! | Ron Truman |
作者: 罗朝天 領域: 医学 審稿時間: 12.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-24 16:15:28 評論於 Slow, very slow(0) 讚! | 罗朝天 |
作者: hepa 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-04-16 08:02:18 評論於 I wrote a review of lncrna, submitted it for revisions ten days ago, received the revisions in three days. Is there anyone faster than me?(0) 讚! | hepa |
作者: 苍风诗云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-15 08:53:58 評論於 Just got accepted today, so fast(0) 讚! | 苍风诗云 |
作者: 灵犀雪梦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-12 16:34:15 評論於 The paper submitted last June was still non-OA, with no article processing charges. But the one submitted yesterday has somehow become OA(0) 讚! | 灵犀雪梦 |
作者: 灵犀雪梦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-12 11:42:39 評論於 Bro, everything going well?(0) 讚! | 灵犀雪梦 |
作者: 苍风诗云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-02 13:14:45 評論於 Review Speed: 1.0 Experience Sharing: I submitted a review article on microRNA related to tumor ten days ago and it was returned for revisions. I hope it will be accepted smoothly(0) 讚! | 苍风诗云 |
作者: 无冬叶吉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-12 09:16:40 評論於 I hope there are no unexpected problems, the publication is pretty good(0) 讚! | 无冬叶吉 |
作者: 玉景开济 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-06 12:39:51 評論於 I asked and they said that proof will start next week, but I'm not sure if it's true. The official website should also be updated by January(0) 讚! | 玉景开济 |
作者: 碧桃瑞红 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-27 21:36:53 評論於 I am too(0) 讚! | 碧桃瑞红 |
作者: 无冬叶吉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-26 10:23:16 評論於 I stopped recently and I don't know why(0) 讚! | 无冬叶吉 |
作者: 碧桃瑞红 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-22 23:51:29 評論於 It's been a month, still inviting reviewers. If we still can't find any, I'll start to panic(0) 讚! | 碧桃瑞红 |
作者: 玉景开济 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-18 11:46:44 評論於 Has this magazine stopped proofreading now? Because they're going fully open access? Or was it always this slow?(0) 讚! | 玉景开济 |
作者: Kim Micah 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-07 12:49:26 評論於 Review speed: 6.0 | Submission acceptance rate: 75.0 Research focus: Tumors; Sharing experience in Meta-analysis: Submitted a Meta-analysis on June 1st, reviewed on June 3rd, revised on October 30th, resubmitted on November 1st, accepted on November 7th. During the external review process, contacted the editor multiple times and received patient replies, overall it was acceptable(0) 讚! | Kim Micah |
作者: 金顶平婉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-16 19:34:58 評論於 Submitted 2 papers, both rejected after over 3 months of submission due to no review comments. Time wasted! Exercise caution when submitting. ——————No.1—————— 2022.9.30 submission received 2022.9.30 reviewers invited (21) 2022.12.28 reviewers invited (22) 2023.1.10 no reviewer accepted review invitation → rejected ——————No.2—————— 2023.5.17 submission received 2023.5.18 reviewers invited (27) 2023.5.25 one reviewer accepted to review 2023.8.27 only one reviewer found and no review comments returned → rejected(0) 讚! | 金顶平婉 |
作者: 灵犀雪梦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-28 12:30:06 評論於 It doesn't matter, when submitting your article, we just mention that there are a few ways to pay for the submission fee, but we don't let you choose(0) 讚! | 灵犀雪梦 |
作者: 千斤凯唱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-28 08:58:15 評論於 I think the editor is quite irresponsible overall, so be careful when submitting! I've wasted seven months on this, and I didn't even receive any editing feedback!(0) 讚! | 千斤凯唱 |
作者: Bert Richards 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-27 18:00:46 評論於 Hello, I would like to ask again. When I submitted the manuscript, I forgot whether I chose OA or non-OA publication. Will it have any impact if I choose non-OA when signing the agreement?(0) 讚! | Bert Richards |
作者: 千斤凯唱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-26 23:20:55 評論於 Well, it's been 7 months and the two reviewers we finally found didn't provide any feedback, so our paper got rejected in the end!(0) 讚! | 千斤凯唱 |
作者: 灵犀雪梦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-25 10:19:44 評論於 Within a week(0) 讚! | 灵犀雪梦 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us